This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of the neoGEN-Series system (RST-Sanexas) for the treatment of neuropathic pain for outcomes including pain, function, quality of life, and safety.

If you have a Hayes login, click here to view the full report on the Knowledge Center.